Using transcranial magnetic stimulation Stern and colleagues showed a significant lack of GABAa-mediated inhibition in patients with Dravet syndrome (SCN1A mutation carriers) [32]. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.